Jeong Han Kim
Overview
Explore the profile of Jeong Han Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
863
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Park G, Kim J, Lee D
BMC Psychol
. 2022 Jan;
10(1):7.
PMID: 34986888
Background: Beliefs about the unacceptability of experiencing or expressing negative emotions can contribute to diverse psychological symptoms and associated with poor treatment outcomes and low treatment attempts. The Beliefs about...
12.
Na J, Kim J, Choe W, Kwon S, Yoo B
Korean J Gastroenterol
. 2021 Jun;
77(6):285-293.
PMID: 34158448
Backgrounds/aims: The HBsAg levels have been used to monitor the chronic hepatitis B (CHB) treatment response to antiviral therapy. On the other hand, it is unclear if the HBsAg quantification...
13.
Kim J, Kim J, Jang J, Jang J, Jin D, Kim Y, et al.
Molecules
. 2021 Jun;
26(9).
PMID: 34063650
Coffee has been shown to attenuate sarcopenia, the age-associated muscle atrophy. Myostatin (MSTN), a member of the TGF-β growth/differentiation factor superfamily, is a potent negative regulator of skeletal muscle mass,...
14.
Yoon J, Jun C, Kim J, Yoon E, Kim B, Song J, et al.
J Korean Med Sci
. 2021 Jun;
36(21):e145.
PMID: 34060260
Background: Chronic hepatitis B is the most common cause of liver cirrhosis in South Korea. However, alcoholic liver disease has shown an increasing trend. Although the clinical implications surrounding liver...
15.
Thomas K, Kim J, Rosenthal D
Am J Psychoanal
. 2020 Dec;
80(4):458-471.
PMID: 33268886
This paper is a follow-up to an article published in 1989 by Cubbage and Thomas. The purpose of that article was to provide a comprehensive analysis of classical Freudian concepts...
16.
Shin S, Yim H, Kim J, Lee C, Yeon J, Suh S, et al.
Gut Liver
. 2020 Oct;
15(3):430-439.
PMID: 33115966
Background/aims: : The clinical significance of partial virological response (PVR) in patients undergoing antiviral therapy is not well known. This study investigated whether PVR after 2 years of entecavir (ETV)...
17.
Wang Q, Wang Z, Xu M, Tu W, Hsin I, Stotland A, et al.
Front Physiol
. 2020 Aug;
11:950.
PMID: 32848877
The accumulation of lipid droplets in the cytoplasm of hepatocytes, known as hepatic steatosis, is a hallmark of non-alcoholic fatty liver disease (NAFLD). Inhibiting hepatic steatosis is suggested to be...
18.
Kim E, Chin B, Kang C, Kim N, Kang Y, Choi J, et al.
J Korean Med Sci
. 2020 Apr;
35(13):e142.
PMID: 32242348
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected pneumonia emerged in Wuhan, China in December 2019. In this retrospective multicenter study, we investigated the clinical course and outcomes of novel...
19.
Kwan B, Kim J, Park S, Choe W, Kwon S, Yoo B
Korean J Intern Med
. 2020 Apr;
36(2):292-304.
PMID: 32241083
Background/aims: Chronic hepatitis C (CHC) treatment has dramatically improved since direct-acting antiviral (DAA) therapy was introduced. However, the use of DAA therapy in CHC patients with hepatocellular carcinoma (HCC) remains...
20.
Park K, Kim J, Choe W, Kwon S, Yoo B, Hwang J, et al.
Korean J Gastroenterol
. 2020 Mar;
75(3):147-156.
PMID: 32209803
Background/aims: A switch to systemic therapy, such as sorafenib, should be considered for hepatocellular carcinoma (HCC) patients refractory to transarterial chemoembolization (TACE). On the other hand, treatment changes are difficult...